Clinical trial
Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline in Pediatric and Young Adults With Primary Brain Tumors (BIO-RIN)
NCT06779487 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline in Pediatric and Young Adults With Primary Brain Tumors (BIO-RIN)
- Lead sponsor
- Tata Memorial Centre
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 11, 2025
- Completion date
- February 29, 2032
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain tumors, ependymoma, glioma, medulloblastoma